Programa - Español

President, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA) Physician, residency training in Pediatrics and Pediatric cardiology, Masters and PhD in Cardiology, MBA in Primary Care. Professor of Clinical Epidemiology and Research Methodology, UFCSPA.

Federico Augustovski es médico de la Universidad de Buenos Aires (UBA) galardonado con un diploma de honor. Se graduó de Máster en Ciencias en Epidemiología en la Harvard School of Public Health y es doctor en Medicina con orientación en Salud Pública (UBA). Realizó cursos de posgrado y experiencias de formación e investigación en evaluaciones económicas y ciencias de la decisión en distintos centros internacionales como la Universidad de York, la Universidad de Texas, y el Baylor College de Medicina de Houston, Estados Unidos. Actualmente, se desempeña como director del Departamento de Evaluación de Tecnologías Sanitarias y Economía de la Salud del Instituto de Efectividad Clínica y Sanitaria, y como profesor adjunto de Salud Pública de la Facultad de Medicina de la UBA. Es investigador del Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina.

En 2017, fue elegido presidente de la Sociedad Internacional de Farmacoeconomía e Investigación de Resultados (ISPOR), el primero en no proceder de Norteamérica o Europa. Es el director del Centro Colaborador OMS/OPS de Evaluación de Tecnologías Sanitarias, y del Centro PROVAC de Argentina para la excelencia en evaluaciones económicas y la toma de decisiones en inmunizaciones. También es médico de familia (se desempeñó como médico de planta de la Unidad de Medicina Familiar y Preventiva del Hospital Italiano de Buenos Aires durante algo más de 20 años) y es director de los cursos de Análisis de Decisiones Sanitarias, de Desarrollo de Cuestionarios en Salud, Evaluaciones Económicas y Sanitarias, Evaluaciones de Tecnologías Sanitarias, y Modelos de Decisión I y II de la Maestría en Efectividad Clínica de la UBA. Fue el primer editor en jefe de la revista Value in Health Regional Issues (hasta diciembre de 2017), publicación con revisión de pares de economía de la salud e investigación de resultados indizada en MEDLINE, y es uno de los fundadores del Consorcio ISPOR para América Latina.

Ha coordinado diversos proyectos académicos y de investigación en el área de la evaluación de tecnologías sanitarias y las evaluaciones económicas en Argentina, Bolivia, Brasil, Chile, Colombia, México, Perú, y Uruguay. Cuenta actualmente con más de 80 publicaciones indizadas en MedLine.

Alec is a Director for FrontierView’s healthcare practice, focusing on Latin America. His work focuses on insights to healthcare decision makers on the evolution of the funding and policy environment within the region. Alec also leads development of our best practices research as it pertains to the healthcare industry and contributes extensive analysis on policy developments impacting market access and reimbursement conditions for innovative therapies. Alec completed a Bachelor’s degree in Political Science, and a Bachelor’s degree in Spanish at Oklahoma State University. He also attended the University of São Paulo where he completed a Master’s in International Political Economy.

Federico Augustovski es médico de la Universidad de Buenos Aires (UBA) galardonado con un diploma de honor. Se graduó de Máster en Ciencias en Epidemiología en la Harvard School of Public Health y es doctor en Medicina con orientación en Salud Pública (UBA). Realizó cursos de posgrado y experiencias de formación e investigación en evaluaciones económicas y ciencias de la decisión en distintos centros internacionales como la Universidad de York, la Universidad de Texas, y el Baylor College de Medicina de Houston, Estados Unidos. Actualmente, se desempeña como director del Departamento de Evaluación de Tecnologías Sanitarias y Economía de la Salud del Instituto de Efectividad Clínica y Sanitaria, y como profesor adjunto de Salud Pública de la Facultad de Medicina de la UBA. Es investigador del Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina.

En 2017, fue elegido presidente de la Sociedad Internacional de Farmacoeconomía e Investigación de Resultados (ISPOR), el primero en no proceder de Norteamérica o Europa. Es el director del Centro Colaborador OMS/OPS de Evaluación de Tecnologías Sanitarias, y del Centro PROVAC de Argentina para la excelencia en evaluaciones económicas y la toma de decisiones en inmunizaciones. También es médico de familia (se desempeñó como médico de planta de la Unidad de Medicina Familiar y Preventiva del Hospital Italiano de Buenos Aires durante algo más de 20 años) y es director de los cursos de Análisis de Decisiones Sanitarias, de Desarrollo de Cuestionarios en Salud, Evaluaciones Económicas y Sanitarias, Evaluaciones de Tecnologías Sanitarias, y Modelos de Decisión I y II de la Maestría en Efectividad Clínica de la UBA. Fue el primer editor en jefe de la revista Value in Health Regional Issues (hasta diciembre de 2017), publicación con revisión de pares de economía de la salud e investigación de resultados indizada en MEDLINE, y es uno de los fundadores del Consorcio ISPOR para América Latina.

Ha coordinado diversos proyectos académicos y de investigación en el área de la evaluación de tecnologías sanitarias y las evaluaciones económicas en Argentina, Bolivia, Brasil, Chile, Colombia, México, Perú, y Uruguay. Cuenta actualmente con más de 80 publicaciones indizadas en MedLine.

Graduated from the Universidade Federal do Rio Grande do Sul Medical School, in Brazil, in 1994. Cnically trained in Internal Medicine and Clinical Oncology by the Hospital de Clinicas de Porto Alegre and attended the University of California San Francisco, as a clinical fellow. Holding an MBA in health business, he is a professor of the post graduation course of Fundação Universidade UNIMED. He also serves as regular consultant of the major private health insurance company in Brazil, with over 100 companies in my portifolio. Currently he is Coordinator of the Oncologic Drugs Benefits Program of the CAPESESP (self financed insurance linked to Ministry of Health). Former Coordinator of the Oncology Unit of UNIMED (with 11 million people covered). He is the author or co-author of over 70 national and international arbitrated journals and chapters of books about oncology, medical audit and pharmacoeconomics and I have presented more than 150 lectures. His work in pharmacoeconomics is focused in cancer related therapy. He is also a founder of the ISPOR Brazilian Chapter and is the current president of the local chapter. Past chair of the ISPOR Latin America Health Care Policymakers & Payers Committee Membership. Board of the Americas Health Foundation. Specialties: Oncology

Medical Oncologist, Director Oncoclínicas Precision Medicine, Oncoclínicas, São Paulo, Brazil

MBA, Esade Business School, Barcelona, Spain

Group Leader, Oncology Data Science Group, Vall d´Hebron Institute of Oncology, Barcelona, Spain

Researcher, Computational Oncology, Sage Bionetworks, Seattle, USA

Researcher, Molecular Pathology, Massachusetts General Hospital, Boston, USA

Medical Oncologist, Molecular Therapeutics Research Unit, Vall d´Hebron Hospital, Barcelona, Spain

Medical Oncologist, Brazilian National Cancer Institute, Rio de Janeiro, Brazil

 

 

.

 

Federico Augustovski es médico de la Universidad de Buenos Aires (UBA) galardonado con un diploma de honor. Se graduó de Máster en Ciencias en Epidemiología en la Harvard School of Public Health y es doctor en Medicina con orientación en Salud Pública (UBA). Realizó cursos de posgrado y experiencias de formación e investigación en evaluaciones económicas y ciencias de la decisión en distintos centros internacionales como la Universidad de York, la Universidad de Texas, y el Baylor College de Medicina de Houston, Estados Unidos. Actualmente, se desempeña como director del Departamento de Evaluación de Tecnologías Sanitarias y Economía de la Salud del Instituto de Efectividad Clínica y Sanitaria, y como profesor adjunto de Salud Pública de la Facultad de Medicina de la UBA. Es investigador del Consejo Nacional de Investigaciones Científicas y Técnicas de Argentina.

En 2017, fue elegido presidente de la Sociedad Internacional de Farmacoeconomía e Investigación de Resultados (ISPOR), el primero en no proceder de Norteamérica o Europa. Es el director del Centro Colaborador OMS/OPS de Evaluación de Tecnologías Sanitarias, y del Centro PROVAC de Argentina para la excelencia en evaluaciones económicas y la toma de decisiones en inmunizaciones. También es médico de familia (se desempeñó como médico de planta de la Unidad de Medicina Familiar y Preventiva del Hospital Italiano de Buenos Aires durante algo más de 20 años) y es director de los cursos de Análisis de Decisiones Sanitarias, de Desarrollo de Cuestionarios en Salud, Evaluaciones Económicas y Sanitarias, Evaluaciones de Tecnologías Sanitarias, y Modelos de Decisión I y II de la Maestría en Efectividad Clínica de la UBA. Fue el primer editor en jefe de la revista Value in Health Regional Issues (hasta diciembre de 2017), publicación con revisión de pares de economía de la salud e investigación de resultados indizada en MEDLINE, y es uno de los fundadores del Consorcio ISPOR para América Latina.

Ha coordinado diversos proyectos académicos y de investigación en el área de la evaluación de tecnologías sanitarias y las evaluaciones económicas en Argentina, Bolivia, Brasil, Chile, Colombia, México, Perú, y Uruguay. Cuenta actualmente con más de 80 publicaciones indizadas en MedLine.

Dr. Monsanto is Executive Director for Latin America of the Center for Observational and Real-world Evidence (CORE) at Merck Sharp & Dohme. He leads a team of scientists in the development and execution of value evidence activities. He was previously Director of Medical Affairs for Latin America, where he spearheaded the development, execution, and dissemination of local data generation studies across the region and supported health economics and outcomes research capability building in the Medical Affairs organization. He joined MSD as Outcomes Research Manager in the Medical Department in Puerto Rico and later was appointed Director of Market Access for Puerto Rico and the Caribbean. Dr. Monsanto has a Bachelor of Science in Pharmacy degree from the University of Puerto Rico, and an MS degree and PhD degrees in Pharmacy Administration from Purdue University in Indiana. He also has an Advanced Certificate in Health and Public Policy from the University of Maryland at Baltimore County. Dr. Monsanto also holds the rank of Professor (Ad Honorem) at the University of Puerto Rico, where he was Professor at the School of Pharmacy prior to joining the pharmaceutical industry. His areas of research interest are healthcare services research, outcomes research and pharmacoeconomics.

He graduated in 1993 from School of Medicine of University of Buenos Aires. He obtained the specialty of Internal Medicine at the Hospital Italiano of Buenos Aires in 1997. He reach his PhD in Informatics Engineering at the Institute Technological of Buenos Aires (ITBA) in the 2016. The same year he obtained a Master of Science Engineering of Information Systems in the Universidad Tecnologica Nacional (UTN).

Certified Professional in Health Information Management System (HIMSS) in 2017. He was one of the creators, and coordinator, of the Medical Informatics Residency at the Hospital Italiano of Buenos Aires. He was responsible for leading the development and implementation of the Clinical Information System of that institution and served as Chief Medical Information Officer for ten years. After that, he took in charge the Health Informatics Department to present days. He also participated in the development of several training programs in the region, including a Spanish version of the OHSU version of the 10x10 program.

Throughout these years he published more than 300 articles in peer review journals, and more than 150 international conferences, is too editor/author of several books/chapters published in the field of Health Informatics. Founding member of the International Academy of Health Sciences Informatics (IAHSI). He is part of the editorial board of Applied Clinical Informatics, the Journal of Health Informatics in Developing Countries, and the Healthcare Informatics Research Journal. Member of AMIA, AHIMA, HIMSS, AAIM.

He participated as Chair and Co-Chair of the Working Group on Health Informatics for Development (WG 09), International Medical Informatics Association (IMIA), and currently is VP for Membership. Besides that he is Professor of Medical Informatics at the Institute University CEMIC and Director of Department of Medical Informatics at the Institute University of the Hospital Italiano in Buenos Aires, Argentina.

Dr. Lina Sofía Palacio-Mejía, is researcher of CONACYT in the National Institute of Public Health of Mexico and the coordinator of the Biostatistics and Health Information System master’s in public health program. I have a PhD in population studies, El Colegio de México, a Master in demography, El Colegio de la Frontera Norte, and a bachelor’s degree in health information systems management, University of Antioquia, Colombia.

The focus of her research is in the production of evidence about the health information system’s strengthening on the performance of the health system and Real World Evidence. She been a consultant for the Health Metrics Network, Measure Evaluation and PAHO.

Claudia Soares is a physician who received her Medical Degree in 1996 and spent 2-years of residency training in Internal Medicine and Cardiology. MSc and PhD in Epidemiology & Biostatistics with focus on epidemiology methods and comparative effectiveness studies using real world data. Second Master in Business Intelligence with focus on data sciences and artificial intelligence methods in healthcare.

Before joining GSK, she worked as an epidemiologist/health outcomes consultant and associated researcher in Academic, Private, Public and Government Institutions, coordinating observational studies, academic and health programs.

Dr. Soares leads Epidemiology, Health Outcomes, Medical Decision Making, Data Collaborations and RWD projects in target Emerging Markets. Dr. Soares focuses on evidence generation strategy and value solutions for marketed and developmental drugs. She works with a combination of data from different sources, to optimize and quantify asset value, studying disease patterns and impact of treatments in multiple therapeutic areas. Dr. Soares is an expert on Causal Inference, Healthcare data sciences, Medical Decision Making and Observational Studies, including Health Outcomes and Comparative Effectiveness Research.

Physician graduated from the Souza Marques School of Medicine (FTESM), associated with the Brazilian Society of Endocrinology and Metabolism, postgraduate degree from the Endocrinology Service of the Hospital dos Servidores do Estado, RJ (HSE) and in Internal Medicine/Medical Clinic from the Universidade Federal do Rio de Janeiro (UFRJ). Director of Indicators at ISPOR Brazil Chapter. Certified professional title with emphasis on Administration by ICSS - Institute for Certification of Social Security Professionals.      

Graduated from the Universidade Federal do Rio Grande do Sul Medical School, in Brazil, in 1994. He is clinically trained in Internal Medicine and Clinical Oncology by the Hospital de Clínicas de Porto Alegre and attended the University of California San Francisco, as a clinical fellow. Holding an MBA in health business, he is a professor of the postgraduation course at the Fundação Universidade UNIMED.

He also serves as regular consultant of the major private health insurance company in Brazil, with over 70 companies in his portfolio. He is Coordinator of the Oncologic Drugs Benefits Program of the CAPESESP (self-financed insurance linked to Ministry of Health) and former Coordinator of the Oncology Unit of UNIMED (with 11 million people covered). He is also a founder of the International Society of Pharmacoeconomic and Outcome Research (ISPOR) Brazilian Chapter, current president elected of the local chapter and former chair of the Latin American Consortium Advisory Committee.  Board of the Americas Health Foundation.

Selenia Gómez holds a bachelor’s degree in Chemistry, Bacteriology and Parasitology from National School of Biological Sciences, and an MBA from School of Commerce and Administration, both at Polytechnical National Institute in Mexico. She has 20 years of experience in healthcare within pharmaceutical industry, with a strong background in pricing and market access for innovative drugs. 

Under her Market Access roles, she has been in charge of diverse therapeutic area projects, at Allergan (which is now part of AbbVie), Roche, Bristol-Myers Squibb and Genzyme, among others. At this moment, she is Pricing and Market Access Director for Allergan, establishing the Market Access function and leading strategies in Mexico, also in charge of public acquisition procedures. She was Business Unit Director for Eyecare and Sub-regional Value and Access Lead supporting Other Latin American Countries Cluster (Argentina, Chile and Colombia).

Selenia has contributed to chemotherapy and parenteral nutrition manufacturing for hospitals and clinics in Mexico as a Pharmacist, and achieved professor certification from Parenteral and Enteral Nutrition Latin-American Federation, FELANPE, in Neonatal Intensive Care Class in 2009.

During 2012-2014, she collaborated with Anahuac University coordinating the Health Economics Class at Master’s in Business and Economy program. She holds different certificates related to Economic Evaluation in Health Technologies, and attended “Quality Strategic Management for Health Organizations” seminar by Harvard School of Public Health in 2015.

As a member of ISPOR Mexico Chapter Board of Directors, she has been able to collaborate with a diversity of initiatives and sessions through different partnerships in her country. 

Surgeon graduated from the UNAM School of Medicine as a Specializing in General Surgery from the HECMN SXXI IMSS, and in Trauma Surgery from the Jackson Memorial Hospital in Miami Florida with a Sub specialization in Colon and Rectal Surgery from the HRLALM of the ISSSTE.

Master of Science from UNAM, Master of Administration from La Salle University, Doctor of Science from Miller School of Medicine and Doctor of Health Economics from York University.

He has more than 25 years of experience in the health sector, participating in the IMSS, ISSSTE Government of Mexico City, Sub-Director of Health Services of Petróleos Mexicanos and currently he serves in the General Health Council in Mexico.
Author of more than 57 articles published in national and international magazines, 17 book chapters and 3 books. Advisor to 48 postgraduate theses.

Full member of various associations such as the Mexican Academy of Surgery, twice winner of the Gabino Barreda medal by UNAM and currently Latin America Executive Chair for ISPOR.

Coronel Médico Cirujano egresado de la Escuela Médico Militar, con estudios de Postgrado en el área de administración y economía de la salud. Experiencia de 5 años como médico de primer nivel en los escalones del servicio de Sanidad Militar. Me he desempeñado en puestos administrativos por más de 15 años en la Dirección General de Sanidad y la Dirección General de Administración de la Secretaría de la Defensa Nacional, realizando análisis económicos para la adquisición de suministros médicos y coordinando los programas relacionados con la prestación de servicios de salud. También laboré como Subdirector Administrativo del Centro Hospitalario del Estado Mayor Presidencia.  En el Hospital Central Militar laboré como Jefe de Normatividad y Jefe de Calidad. En el Consejo de Salubridad General me desempeñé como Subdirector de Investigación en el área de Certificación de Establecimientos de Atención Médica. Cuento con experiencia docente y académica tanto en la Universidad del Ejercito y Fuerza Aérea como en diversas Universidades del medio civil tales como la Universidad Nacional Autónoma de México, Universidad Anáhuac, y el Instituto Tecnológico de Estudios Superiores de Monterrey, entre otras, en las cátedras de Políticas, Planeación y Economía de la Salud. He publicado diversos artículos científicos de mi especialidad. Actualmente me desempeño como Jefe Regional del Servicio de Sanidad en los estados de Nuevo León, Tamaulipas y San Luis Potosí coordinando a los escalones de Sanidad Militar, y con motivo de la situación sanitaria que prevalece en el país a consecuencia de la pandemia por el virus SARS-CoV-2, también realizo la coordinación para la presentación de los servicios de atención médica dentro del Plan DN-III-E de 4 hospitales INSABI que administra la Secretaría de la Defensa Nacional y 2 Unidades Operativas de Hospitalización y Terapia Intensiva donde se atienden pacientes con COVID 19.

Javier cofounded the company and has dedicated his entire professional career to healthcare in different landscapes, focusing on developing innovative solutions to help people get access to the best health services.

Javier has collaborated with governments, health industry associations, hospitals, healthcare providers, medical device companies, diagnosis device companies, health insurance companies and, above all, the pharmaceutical industry, to align needs and incentives through innovation. That innovation is backed by a solid quantitative background, with the goal of implementing healthcare policies that are effective in the public sector as well as the private sector.

Javier is an engineer with a master’s degree in applied economics as well as health economics. He is currently developing his doctoral dissertation on “The Value of Health.”

Claudine, Senior Partner of Research Power Inc., a Canadian based Health and Research Consulting Company, is an experienced trainer, facilitator, researcher, and project manager. With over 20 years of consulting experience in the healthcare sector, Claudine does extensive international consulting in the public and private health sector. 
Claudine has a graduate degree in Community Heath and Epidemiology with a focus in research methodologies, statistics, and data interpretation.

• Pharmacist, Epidemiologist and Health Economist. MBA (actual). 12 years of experience and extensive knowledge in different actors of the Colombian Health sector (Healthcare Providers, HMO´s, logistics operation - PBM, Ministry of Health, Academia). 
• Student MSc Health Policy, Planning and Financing LSE/LSHTM- London, UK. 
  -Current President of ISPOR Colombia and General Manager of the consulting firm InValue. 
• Postgraduate Teacher at Salud Universidad Jorge Tadeo Lozano.

Experienced health economist, line manager and coach. Well versed in the complex UK health environment with experience spanning consultancy, academia, and pharma. Nicola has a graduate degree in Mathematics and focus on Mathematical modeling and Numerical Simulation of Complex Fluids.

Founder and director of LAPA (Latin America Patients Academy) has more than 20 years of experience providing strategic leadership, development and global health policy analysis and implementation. She is a global leader in patient-based organizational capacity building, patient involvement and alliance development covering several therapeutic areas, including cancer, NCDs and rare diseases. She is expert at organizing forums and building coalitions of patient groups, physicians, public health specialists and government officials to generate dialogue and action plans to address a variety of public health issues. Eva Maria was Director General of the Peruvian Ministry of Health’s (MINSA) International Coordination office and, before that, served as MINSA’s Director General of Health Prevention and Promotion. An industrial engineer by training, Eva Maria has a Master’s degree in Political Science from the Sorbonne University in Paris and her DEA-PhD studies in Economic Development from the École des hautes études en sciences sociales EHESS in Paris.

Dr. Kanavos has previously been Harkness Fellow in Health Care Policy in the Department of Ambulatory Care and Prevention, Harvard Medical School and has held visiting professor appointments at the University of Basel, the University of Delaware and the London School of Hygiene and Tropical Medicine. He is an economist by training, and teaches health economics, pharmaceutical economics and policy, health care financing, health care negotiations, and principles of health technology assessment.

He has acted as an advisor to a number of international governmental and non-governmental organizations, including the European Commission, the European Parliament, the World Bank, the World Health Organization, the Organization for Economic Co-operation and Development (OECD), the American Association for Retired Persons, and Ministries of Health of over 28 transition, emerging and developing countries.

Current research

Dr. Kanavos' research interests include comparative health policy and healthcare reform, pharmaceutical economics and policy from a developed and developing country perspective, quality and access in healthcare, and socio-economic determinants of health.

He leads the activities of MTRG, which is a research group comprising of 13 researchers and concentrates on interdisciplinary and comparative policy research on medical technologies. The group conducts research on a number of research streams. As part of its activities, MTRG is currently co-ordinating the activities of the IMPACT HTA consortium, an EU H2020 grant, and has previously coordinated the activities of key research grants on Health Technology Assessment (Advance HTA project), on Chronic Disease and a component of Best Practices in Rare Diseases. It has conducted research under the auspices of and participated in the European Medicines Information Network (EMI-net) and the network for the study of rare diseases. It also coordinates the activities of The Patient Academy, an initiative between academia, health care regulatory agencies and patient groups.

Executive Director, Cuenta de Alto Costo, Bogotá, Colombia

 

 

.

Cardiologist with A PhD In cardiology, MBA In Health Management and a Masters Degree in Care Transformation by the Value Institute for Health and Care, University Of Texas At Austin. She is VBHC Center Europe Ambassador for Brazil and Co-Chair Of The VBHC Initiative for the American College Of Cardiology.

Licenciada en Economía (UNLP). Magíster en Finanzas Públicas, Provinciales y Municipales (UNLP). Especialista en regulación de servicios públicos.

Actualmente se desempeña como Jefa de Gabinete del Ministerio de Salud de la Nación. Directora de la Maestría de Farmacopolíticas de la Universidad ISALUD y docente titular de grado y posgrado de la Universidad Nacional de La Plata (UNLP) y de la Universidad ISALUD.

Es miembro del Consejo Académico del Diplomado en Economía de la Salud de la Universidad Dr. José Matías Delgado de El Salvador.

Se desempeñó como Subsecretaria de Medicamentos e información estratégica y Directora de Economía de la Salud del Ministerio de Salud de la Nación, Asesora en Política de Medicamentos, Farmacoeconomía e Industria Farmacéutica.

Realizó numerosos trabajos de consultoría e investigación en evaluación de programas sanitarios, análisis de mercados sanitarios, propiedad intelectual, evaluación económica, finanzas públicas, entre otros a nivel local e internacional.

Ex presidenta y ex tesorera de la Asociación de Economía de la Salud de Argentina, y actual miembro de la comisión directiva.

Autora y coautora de libros, capítulos de libros y artículos especializados. 

Vania Canuto is a health economist and currently a Director at the Brazilian Public Health System’s National Commission for Health Technologies Incorporation (CONITEC), where she has worked at since 2011. From 2002 to 2009, she worked on price regulation of medicines in the Pharmaceutical Market Regulation Chamber (CMED) in Brazil.

Vania Canuto es economista de la salud y actualmente es directora de la Comisión Nacional de Incorporación de Tecnologías Sanitarias (CONITEC) del Sistema Público de Salud de Brasil, donde trabaja desde 2011. De 2002 a 2009, trabajó en la regulación de precios de medicamentos en la Cámara de Regulación del Mercado de Medicamentos (CMED) en Brasil.

Executive Director, Instituto de Evaluación Tecnológica en Salud (IETS), Bogotá, Colombia

 

 

 

 

 

.

General Manager of Latin America, Bristol Myers Squib, and Chair of FIFARMA (2021-2022), Buenos Aires, Argentina

 

 

.

Luis Tejerina is a Lead Specialist in the IDB's Social Protection and Health Division, where he works on digital transformation projects in the social sector, and on tools to promote the most efficient and effective use of technology. He has a Masters in Economics from the University of Maryland and has led the implementation of a digital transformation agenda in the social protection and health sectors.

Marcela Pérez is a passionate woman working on health innovations that positively impact people's lives. She has a background in biomedical sciences, MSc in Oncology- USP Brazil, and currently PhD Oncology candidate- UNAL Colombia. Experience in the academic and in the Pharma sector specially in Oncology, Public Health, and Health Economics. Her main research topic is health inequalities.

Currently Marcela is the Senior Value & Access Manager for Latin America North in Janssen.

Yajaira Bastardo es profesora y jefe de la Catedra de Farmacoeconomía y Administración de Farmacia de la Universidad Central de Venezuela. Ella también imparte cursos de postgrado en farmacoeconomía en el Postgrado de Vigilancia Sanitaria de Medicamentos del Instituto Nacional de Salud "Rafael Rangel" en Caracas, Venezuela. Ella recibió su título de farmacéutico de la Universidad Central de Venezuela y, en 2010, completó un doctorado en Administración de Atención Farmacéutica en la Universidad de Florida.

La Dra. Bastardo ha ocupado varios cargos en la Facultad de Farmacia de la Universidad Central de Venezuela incluyendo director administrativo (2010-2011), director del Departamento Administrativo y Legal, coordinadora de la Mención Sanitario Asistencial y de la Mención de Microbiología Aplicada, jefe de la Cátedra de Microbiología Aplicada, y jefe de la Sección de Medios de Cultivo. Ella ha realizado investigaciones y publicado en la investigación de resultados de salud. Sus principales intereses de investigación incluyen la calidad de vida, la toma de decisión en salud, y la adherencia a la terapia.

Ella es miembro fundador del Consorcio ISPOR para América Latina y presidente fundador del capítulo regional ISPOR Venezuela. Ha servido ISPOR en varias funciones: copresidente del Subcomité de cursos cortos de conferencias ISPOR para América Latina durante del 2010-2012, copresidente del Subcomité de Investigación durante la 3ª Conferencia ISPOR para América Latina, miembro del grupo de trabajo para la implementación de la Visión ISPOR 2020, editor en jefe del boletín electrónico News Across Latin America. Actualmente, es presidente electa del capítulo regional ISPOR Venezuela y presidente electa del Consorcio ISPOR para América Latina para 2018-2020.